Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,897 | 50 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $445.97 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $355.64 | 9 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $301.06 | 7 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $146.53 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 1 | $0 (2024) |
| Tris Pharma Inc | $108.85 | 1 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $104.95 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $87.46 | 5 | $0 (2024) |
| Lundbeck LLC | $69.72 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $51.17 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,208 | 32 | Janssen Pharmaceuticals, Inc ($196.35) |
| 2023 | $217.90 | 12 | ABBVIE INC. ($80.56) |
| 2022 | $470.60 | 6 | ABBVIE INC. ($195.99) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $115.20 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $101.67 | General |
| Category: Insomnia | ||||||
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.12 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Insomnia | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Neuroscience | ||||||
| 07/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Insomnia | ||||||
| 07/23/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $104.95 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Insomnia | ||||||
| 06/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.78 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Central Nervous System | ||||||
| 05/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $111.66 | General |
| Category: Neuroscience | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Tris Pharma Inc | Dyanavel XR (Drug), Quillivant, Quillichew ER | Food and Beverage | In-kind items and services | $108.85 | General |
| Category: ADHD | ||||||
| 04/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: NEUROSCIENCE | ||||||
| 04/10/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: NEUROLOGY | ||||||
| 04/10/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Neuroscience | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 81 | 82 | $62,701 | $6,443 |
| 2022 | 3 | 90 | 91 | $125,333 | $8,863 |
| 2021 | 4 | 134 | 139 | $90,426 | $11,144 |
| 2020 | 4 | 160 | 166 | $124,314 | $11,724 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 43 | 44 | $34,940 | $3,386 | 9.7% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 17 | 17 | $18,280 | $2,018 | 11.0% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 21 | 21 | $9,481 | $1,039 | 11.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 44 | 44 | $77,493 | $5,627 | 7.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 24 | 24 | $27,960 | $2,059 | 7.4% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 22 | 23 | $19,880 | $1,177 | 5.9% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 51 | 53 | $50,976 | $6,108 | 12.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 48 | 51 | $32,202 | $4,273 | 13.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 15 | 15 | $6,008 | $657.88 | 11.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 20 | 20 | $1,240 | $105.83 | 8.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 50 | 52 | $60,850 | $5,994 | 9.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 50 | 51 | $37,215 | $3,966 | 10.7% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 47 | 47 | $25,257 | $1,672 | 6.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 13 | 16 | $992.00 | $91.57 | 9.2% |
About Michael Forehand, ARNP
Michael Forehand, ARNP is a Nurse Practitioner healthcare provider based in Thomasville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730133521.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Forehand, ARNP has received a total of $1,897 in payments from pharmaceutical and medical device companies, with $1,208 received in 2024. These payments were reported across 50 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,897).
As a Medicare-enrolled provider, Forehand has provided services to 465 Medicare beneficiaries, totaling 478 services with total Medicare billing of $38,174. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location Thomasville, GA
- Active Since 05/19/2006
- Last Updated 08/20/2013
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1730133521
Products in Payments
- VRAYLAR (Drug) $426.93
- SPRAVATO (Drug) $355.64
- QUVIVIQ (Drug) $301.06
- Austedo XR (Drug) $125.00
- FANAPT (Drug) $115.20
- Dyanavel XR (Drug) $108.85
- Qelbree (Drug) $104.95
- TRINTELLIX (Drug) $87.46
- REXULTI (Drug) $83.76
- CAPLYTA (Drug) $44.82
- HETLIOZ (Drug) $31.33
- VENCLEXTA (Biological) $25.34
- QULIPTA (Drug) $19.04
- NUEDEXTA (Drug) $18.92
- ABILIFY MAINTENA (Drug) $18.21
- Wegovy (Drug) $15.37
- ANDEXXA (Biological) $14.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Thomasville
Mrs. Roumyana Spassova, Fnp, FNP
Nurse Practitioner — Payments: $5,300
Brittni Harrell, Crnp, CRNP
Nurse Practitioner — Payments: $4,591
Leslie Stanaland, N.p, N.P
Nurse Practitioner — Payments: $3,788
Caitlin Suddarth, Np-C, NP-C
Nurse Practitioner — Payments: $3,054
Ms. Rachel Burns, Np, NP
Nurse Practitioner — Payments: $2,037
Brandi Cash, Np, NP
Nurse Practitioner — Payments: $1,432